Keeping Track: Recent NDA Submissions Range From Acute Agitation To Von Hippel-Lindau Disease

 
• By Bridget Silverman

News and highlights of applications submitted for US FDA approval, from the Pink Sheet’s FDA Performance Tracker

This edition of Keeping Track features nothing but NDAs

More from US FDA Performance Tracker

More from Regulatory Trackers